<i>ASXL1/TET2</i> genotype-based risk stratification outperforms <i>ASXL1</i> mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia

oleh: Clifford M. Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly Chien, Danielle Hammond, Terra L. Lasho, Christy M. Finke, Christopher Dean, Anuya Natu, Abhishek A. Mangaonkar, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Rami S. Komrokji, Najla A. Ali, Eric Padron, Guillermo Montalban-Bravo, Mrinal M. Patnaik

Format: Article
Diterbitkan: Ferrata Storti Foundation 2024-06-01

Deskripsi

Not available.